Dimethyl Fumarate: A Review in Moderate to Severe Plaque Psoriasis.

about

Dimethyl fumarate is an allosteric covalent inhibitor of the p90 ribosomal S6 kinases

P2860

Q57810919-2F984508-D1C8-4573-9B39-0AD78F7ADBCA

P2860

Dimethyl Fumarate: A Review in Moderate to Severe Plaque Psoriasis.

Item

http://www.wikidata.org/entity/Q47318089

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Dimethyl Fumarate: A Review in Moderate to Severe Plaque Psoriasis.

@en

Dimethyl Fumarate: A Review in Moderate to Severe Plaque Psoriasis.

@nl

type

Item

label

Dimethyl Fumarate: A Review in Moderate to Severe Plaque Psoriasis.

@en

Dimethyl Fumarate: A Review in Moderate to Severe Plaque Psoriasis.

@nl

prefLabel

Dimethyl Fumarate: A Review in Moderate to Severe Plaque Psoriasis.

@en

Dimethyl Fumarate: A Review in Moderate to Severe Plaque Psoriasis.

@nl

P1476

Dimethyl Fumarate: A Review in Moderate to Severe Plaque Psoriasis.

@en

P2093

Hannah A Blair

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro pharmacokinetics of anti-psoriatic fumaric acid esters

Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials.

Methotrexate vs. fumaric acid esters in moderate-to-severe chronic plaque psoriasis: data registry report on the efficacy under daily life conditions.

Fumaric acid esters for severe psoriasis: a retrospective review of 58 cases.

Dimethylfumarate specifically inhibits the mitogen and stress-activated kinases 1 and 2 (MSK1/2): possible role for its anti-psoriatic effect.

Fumaric acid esters for psoriasis: a systematic review.

Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest.

Progressive multifocal leukoencephalopathy associated with fumaric acid esters treatment in psoriasis patients.

Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents.

Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions.

P2888

s40265-017-0854-6

P304

123-130

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1007/S40265-017-0854-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29236231

http://www.w3.org/2001/XMLSchema#string

Dimethyl Fumarate: A Review in Moderate to Severe Plaque Psoriasis.

about

P2860

P2860

Dimethyl Fumarate: A Review in Moderate to Severe Plaque Psoriasis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698